Studying human liver organoids for a fatty liver disease called NASH
Part of Digestive system clinical trials.
This study takes small samples of liver tissue to grow 3D 'mini livers' (organoids) in the lab. Researchers want to learn how non-alcoholic steatohepatitis (NASH), a serious fatty liver condition, starts and progresses, which could lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult and have agreed to be in the study.
- You fit one of these situations: having a liver biopsy for suspected NASH, having part of your liver removed for cancer or other growths, a healthy liver biopsy after transplant, or gallbladder removal surgery.
- You are willing to give a blood sample and let the study use your DNA and medical records.
- You do not have active viral hepatitis (like hepatitis B or C) or other specific liver diseases (like autoimmune hepatitis, hemochromatosis, alpha-1-antitrypsin deficiency, or Wilson's disease).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects health information and samples from people with non-alcoholic fatty liver disease to better understand the condition. It may help researchers find new ways to diagnose or treat this liver problem.
This trial tests whether a very low calorie ketogenic diet (a strict low-carb, high-fat diet) can help people with non-alcoholic steatohepatitis (NASH) who have liver scarring. Participants will follow this diet for a year and have two liver biopsies to see if their liver health improves.
This study collects health information from people with non-alcoholic fatty liver disease (NAFLD), a condition where fat builds up in the liver. It aims to learn more about the disease to improve future care.
This study looks at a protein called Suv420h1/2 in liver cells to understand its role in liver disease. It uses stored samples and data from people who already took part in related studies.
This registry collects health and lifestyle information from adults with suspected or confirmed fatty liver (NAFLD) to help researchers better understand the condition. You may be asked about diet, exercise, alcohol intake, and some liver-related tests.
This study collects information about metabolic and unexplained (cryptogenic) liver disease and looks at “omics” tests, which are lab tests that measure patterns in blood or tissue to learn what drives the disease. It may help researchers better understand fatty liver and related serious complications, like liver scarring and liver cancer.
Hear when a new NAFLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.